← Leaderboards
Jung-Min Lee
Division Of Basic Sciences - Nci
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Division Of Basic Sciences - Nci
Same institution · by research overlap
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorProgramsResponseTranslational ResearchDna RepairMalignant NeoplasmsProteinsResearch PersonnelTherapeutic TargetPre-ClinicalWomanBiological MarkersPhase 2 StudyPathway InteractionsBiopsyMalignant Neoplasm Of OvaryMutationClinical TrialsDrug CombinationsCancer PatientCell Cycle CheckpointLaboratoriesNovel TherapeuticsRecurrence
Grant awards (13)
Leveraging DNA damage repair pathways as therapeutic targets in womens cancers$2,194,470
ZIA · FY2025 · CA · contact PI
Leveraging DNA damage repair pathways as therapeutic targets in womens cancers$1,833,254
ZIA · FY2024 · CA · contact PI
Leveraging DNA damage repair pathways as therapeutic targets in womens cancers$1,729,738
ZIA · FY2023 · CA · contact PI
Leveraging DNA damage repair pathways as therapeutic targets in womens cancers$1,301,281
ZIA · FY2022 · CA · contact PI
Leveraging DNA damage repair pathways as therapeutic targets in womens cancers$1,202,994
ZIA · FY2021 · CA · contact PI
Leveraging DNA damage repair pathways as therapeutic targets in womens cancers$1,423,817
ZIA · FY2020 · CA · contact PI
Leveraging DNA damage repair pathways as therapeutic targets in womens cancers$1,092,801
ZIA · FY2019 · CA · contact PI
Leveraging DNA damage repair pathways as therapeutic targets in womens cancers$1,058,087
ZIA · FY2018 · CA · contact PI
Leveraging DNA damage repair pathways as therapeutic targets in womens cancers$745,273
ZIA · FY2017 · CA · contact PI
Leveraging DNA damage repair pathways as therapeutic targets in womens cancers$597,694
ZIA · FY2016 · CA · contact PI
Leveraging DNA damage repair pathways as therapeutic targets in womens cancers$661,211
ZIA · FY2015 · CA · contact PI
Targeting DNA damage repair and related pathways in HRD-womens cancers$773,642
ZIA · FY2014 · CA · contact PI
Targeting DNA damage repair and related pathways in HRD-womens cancers$141,489
ZIA · FY2013 · CA · contact PI